1. Home
  2. SLXN vs EVOK Comparison

SLXN vs EVOK Comparison

Compare SLXN & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • EVOK
  • Stock Information
  • Founded
  • SLXN 2008
  • EVOK 2007
  • Country
  • SLXN Israel
  • EVOK United States
  • Employees
  • SLXN N/A
  • EVOK N/A
  • Industry
  • SLXN
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLXN
  • EVOK Health Care
  • Exchange
  • SLXN NYSE
  • EVOK Nasdaq
  • Market Cap
  • SLXN 7.6M
  • EVOK 7.1M
  • IPO Year
  • SLXN N/A
  • EVOK 2013
  • Fundamental
  • Price
  • SLXN $1.26
  • EVOK $4.81
  • Analyst Decision
  • SLXN Strong Buy
  • EVOK
  • Analyst Count
  • SLXN 1
  • EVOK 0
  • Target Price
  • SLXN $9.00
  • EVOK N/A
  • AVG Volume (30 Days)
  • SLXN 32.1M
  • EVOK 10.0K
  • Earning Date
  • SLXN 02-21-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • SLXN N/A
  • EVOK N/A
  • EPS Growth
  • SLXN N/A
  • EVOK N/A
  • EPS
  • SLXN N/A
  • EVOK N/A
  • Revenue
  • SLXN N/A
  • EVOK $8,617,036.00
  • Revenue This Year
  • SLXN N/A
  • EVOK $97.35
  • Revenue Next Year
  • SLXN N/A
  • EVOK $99.52
  • P/E Ratio
  • SLXN N/A
  • EVOK N/A
  • Revenue Growth
  • SLXN N/A
  • EVOK 100.35
  • 52 Week Low
  • SLXN $0.21
  • EVOK $3.54
  • 52 Week High
  • SLXN $13.56
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • EVOK 59.77
  • Support Level
  • SLXN N/A
  • EVOK $4.68
  • Resistance Level
  • SLXN N/A
  • EVOK $4.94
  • Average True Range (ATR)
  • SLXN 0.00
  • EVOK 0.28
  • MACD
  • SLXN 0.00
  • EVOK 0.06
  • Stochastic Oscillator
  • SLXN 0.00
  • EVOK 73.58

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: